Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer

This publication has 20 references indexed in Scilit:

• Intraperitoneal Chemotherapy for Ovarian Carcinoma: Results of Long-Term Follow-Up
  Journal of Clinical Oncology, 2002
• Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis
  European Journal of Surgical Oncology, 2001
• Extensive cytoreductive surgery combined with intra-operative intraperitoneal perfusion with cisplatin under hyperthermic conditions (OVHIPEC) in patients with recurrent ovarian cancer: a feasibility pilot
  European Journal of Surgical Oncology, 2000
• Intraperitoneal α-Interferon Alternating with Cisplatin in Residual Ovarian Carcinoma: A Phase II Gynecologic Oncology Group Study
  Gynecologic Oncology, 1999
• Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma
  Cancer, 1999
• A Phase II Trial of Intraperitoneal Cisplatin and Etoposide as Consolidation Therapy in Patients with Stage II–IV Epithelial Ovarian Cancer Following Negative Surgical Assessment
  Gynecologic Oncology, 1998
• Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery
  Cancer, 1997
• Differential thermal sensitivity of tumour and normal tissue microvascular response during hyperthermia
  International Journal of Hyperthermia, 1992
• Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy
  Gynecologic Oncology, 1991
• Apoptosis induced by mild hyperthermia in human and murine tumour cell lines: A study using electron microscopy and DNA gel electrophoresis
  The Journal of Pathology, 1991